Akoustis Technologies, INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
Blue Owl Capital Holdings LP has filed a Schedule 13G, reporting beneficial ownership of 5.92% of Aktis Oncology, Inc. common stock as of March 31, 2026.